FDA.reportPublic FDA data

Amyloid B component IVD, antibody

Definition
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of amyloid B component in a clinical specimen.
GUDID devices
10
Last updated
2026-06-13 06:05:13

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
05700572005971Mono Mo A-Hu Beta-Amyloid Cl 6F/3DAGILENT TECHNOLOGIES SINGAPORE PTE LTDM08722020-09-17
B502BSB34410Tinto Amyloid Beta, RMabBIO SB, INC.Predilute, 3 ml 2020-06-01
B502BSB34420Tinto Amyloid Beta, RMabBIO SB, INC.Predilute, 7 ml 2020-06-01
B502BSB34430Tinto Amyloid Beta, RMabBIO SB, INC.Predilute, 15 ml 2020-06-01
B502BSB34440Amyloid Beta RMabBIO SB, INC.Concentrate, 0.1 ml2020-03-16
B502BSB34450Amyloid Beta RMabBIO SB, INC.Concentrate, 0.5 ml2020-03-16
B502BSB34460Amyloid Beta RMabBIO SB, INC.Concentrate, 1 ml2020-03-16
L502BSB3444Amyloid Beta RMabBIO SB, INC.Concentrate, 0.1 ml2020-03-16
L502BSB3445Amyloid Beta RMabBIO SB, INC.Concentrate, 0.5 ml2020-03-16
L502BSB3446Amyloid Beta RMabBIO SB, INC.Concentrate, 1 ml2020-03-16